Date: 2014-01-07 14:36:35

Apoptosis

Bcl-2

Genes

Oncology

Monoclonal antibody therapy

Diffuse large B-cell lymphoma

Biology

Medicine

Lymphoma

ProNAi Therapeutics Reports Anti-Tumor Activity from Ongoing Phase II Clinical Study of PNT2258, a Novel BCL2-Inhibitor, at ASH Annual Meeting December 09, :00 PM Eastern Standard Time ASH 2013 PLYMOUTH, Mich.--(B

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 165,75 KB